CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Bibliometric analysis of global research trends in pancreatic cancer immunotherapy.
Bibliometric analysis of global research trends in pancreatic cancer immunotherapy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
胰腺癌是一种高度恶性的肿瘤,预后差且治疗手段有限。免疫治疗在改善预后方面显示出前景,但该领域的文献计量学分析却十分匮乏。我们的工作揭示了新兴趋势,识别了研究空白,并突出了关注点的转变,为免疫治疗的未来研究和临床实践提供了有价值的指导。利用CiteSpace、VOSviewer和RStudio等工具对胰腺癌免疫治疗进行了文献计量学分析,重点关注时空分布、重要作者、研究主题、关键词和引文网络。分析显示,过去十年中胰腺癌免疫治疗的研究活动显著增加,热点包括ICIs、CAR-T 疗法、新型生物标志物、靶向治疗、肿瘤微环境和个性化治疗策略。本研究系统回顾了1991年至2024年胰腺癌免疫治疗的研究进展,突出了关键热点和趋势。未来的努力应集中在ICIs、CAR-T 疗法和联合策略上,以提高疗效并延长患者生存期。
Pancreatic cancer is a highly malignant tumor with poor prognosis and limited treatments. Immunotherapy shows promise in improving outcomes, but bibliometric analyses in this field are scarce.
Our work reveals emerging trends, identifies research gaps, and highlights shifts in focus, offering valuable guidance for future research of immunotherapy and clinical practice. Pancreatic cancer immunotherapy bibliometric analyses were performed utilizing tools such as CiteSpace, VOSviewer, and RStudio, with a focus on the temporal and spatial distribution, prominent authors, research themes, keywords, and citation networks.
The analysis reveals a significant increase in research activity on pancreatic cancer immunotherapy over the past decade, with hotspots including ICIs, CAR-T therapy, novel biomarkers, targeted therapies, the tumor microenvironment, and personalized treatment strategies.
This study systematically reviews pancreatic cancer immunotherapy research progress from 1991 to 2024, highlighting key hotspots and trends. Future efforts should focus on ICIs, CAR-T therapy, and combination strategies, to enhance outcomes and extend patient survival.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。